US government reclassifies cannabis as less hazardous substance

The US Department of Justice has announced plans to reclassify cannabis under the Controlled Substances Act. The move is expected to expand research opportunities and potentially lead to changes in how marijuana products are regulated.

According to reports, the Trump administration will reclassify cannabis as a Schedule III drug, which is considered less dangerous than previously classified substances such as heroin and LSD. This change could pave the way for increased research into the medical benefits of cannabis and its potential uses in treating various conditions.

The Department of Justice has stated that the reclassification is intended to facilitate scientific study and exploration of the therapeutic properties of cannabis. However, details on how this will be implemented are still unclear.

Several news outlets have reported on the development, citing sources within the administration. The changes are expected to take effect as early as Wednesday, according to Axios reports.

The move has sparked interest among researchers, policymakers, and industry stakeholders, who are eager to see how the reclassification will impact the regulation of cannabis products.

Source: Google News World